PL EN

EMEA: CHMP Recommendations for the Pharmacovigilance Plan as part of the Risk Management Plan to be submitted with the Marketing Authorisation Application for a Pandemic Influenza Vaccine (EMEA/359381/2009)

27.07.2009
This document applies to the pharmacovigilance plan as part of the risk management plan introduced with the authorisation application of mock-up pandemic influenza vaccines according to the CHMP Guideline on dossier structure and content of pandemic influenza vaccine marketing authorisation application (CPMP/VEG/17/17/03). It also applies to the pharmacovigilance plan of vaccines authorised outside the context of the mock-up dossier and to be used during an influenza pandemic.

kapitał ludzki

fundusz społeczny

Narodowe Centrum Badań i Rozwoju

innowacyjna gospodarka

rozwój regionalny